Saturday, November 23, 2024
HomeTagsZYESAMI

ZYESAMI

NRx Pharmaceuticals Announces Data Safety Monitoring Board (DSMB) Update on U.S. National Institutes of Health (NIH) Study of ZYESAMI (aviptadil) in Critical COVID-19

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced results of a review conducted by the Data Safety and Monitoring Board (DSMB) on May 25,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics